Bispecific and costimulatory targeting shows early activity in MSS colorectal cancer
A phase 1b trial combining a bispecific T cell engager with a tumour-targeted costimulatory agent…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
S4 E2: iCCA, Chrono-Oncology + Genomic Therapy Matching
From cholangiocarcinoma to chrono-oncology, this episode explores whether promising signals are ready to translate into meaningful patient benefit. With thanks to our Host Craig Underhill, joined by Dr Kate Clarke and Professor Christopher Jackson…
A urine test that could change the course of bladder cancer care
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and…
New guidance for UK GPs aims to cut delays in childhood cancer diagnosis
Expert guidance has been released today by a leading children and young people’s cancer charity…
Cancer risk is significantly higher for adults who never married
Adults who have never been married face a significantly higher risk of developing cancer than…
Study identifies strategy to overcome radiation therapy resistance in lung cancer
In a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research,…
New method makes cancer cells more visible to immune system
A new method making cancer cells more visible to the immune system could improve how…
ASH and ISTH publish new clinical practice guidelines on anticoagulant prophylaxis in pediatric patients at risk of blood clots
The American Society of Haematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH)…
New advances in understanding how the most common form of childhood cancer originates
B-cell acute lymphoblastic leukaemia is the most common form of childhood cancer. In this type of…
Why anti-cancer drugs do not always live up to expectations
For over a decade, a class of drugs called BET inhibitors has been tested in…